- Opportunity and Forecast, 2016 - 2025
Phytosterols, also known as plant sterols, are a family of molecules found in cell membranes of common vegetables and plants. These are related to cholesterol functionally, and their primary source is vegetable oils. They play a vital role in human nutrition, and are obtained on consumption of nuts, seeds, fruits, and vegetables. Aforementioned components are added in processed food products as they lower cholesterol absorption, leading to lower blood cholesterol value. In addition, studies suggest that phytosterol consumption facilitates in reducing risk of cancer, such as lung, breast, stomach, and ovarian, along with lowering rate of growth of tumors.
Favorable regulatory scenario, increase in prevalence of heart diseases, and growth in food & beverage industry drive the global phytosterols industry. Threat of substitute from other functional food ingredients, along with lack of consumer awareness, limits the growth of this market. However, benefits offered by phytosterols such as regulation of brain function, lowering of carcinogenic risk, and maintenance of heart rate are expected to offer new opportunities for industry players.
The global phytosterols market is segmented on the basis of product type, application, and geography. Based on product type, the market is divided into beta-sitosterol, campesterol, and stigmasterol. By application, it is categorized into pharmaceuticals, food ingredients, and cosmetics. Geographically, it is analyzed across North America, Asia-Pacific, Latin America, Europe, and Middle East and Africa.
Key players operating in this market include ADM, BASF, Cargill, DuPont, Raisio, Arboris, FenchChem, PrimaPharm, DRT, and Lipofoods. These players have adopted new product launches, collaborations, partnerships, joint ventures, expansion, mergers & acquisitions, and other developmental strategies to strengthen their position in the global industry.
The global monoclonal antibody market was valued at $76,899 million in 2014 and is estimated to reach $214,922 million by 2025, registering a CAGR of 9.8% from 2018 to 2025. Read More >>